Logo for Actinogen Medical Limited

Actinogen Medical Investor Relations Material

Latest events

Logo for Actinogen Medical

Q1 2025 TU

28 Oct, 2024
Logo for Actinogen Medical

H2 2024

29 Aug, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies

Latest reports from Actinogen Medical Limited

Access all reports
Actinogen Medical Limited is a biotechnology company focused on the development of treatments for cognitive impairment and neurodegenerative diseases. The company’s primary research centers on therapies that target neurological pathways involved in conditions such as Alzheimer's disease and other forms of cognitive decline. Actinogen Medical leverages its proprietary drug development platform to create innovative solutions aimed at improving brain health and cognitive function. Actinogen Medical Limited is headquartered in Sydney, Australia, and its shares are listed on the ASX.